Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A new facility for airborne solar astronomy: NASA's WB-57 at the 2017 total solar eclipse

Autor: Caspi, Amir, Seaton, Daniel B., Tsang, Constantine C. C., DeForest, Craig E., Bryans, Paul, DeLuca, Edward E., Tomczyk, Steven, Burkepile, Joan T., Casey, Thomas "Tony", Collier, John, Darrow, Donald "DD", Del Rosso, Dominic, Durda, Daniel D., Gallagher, Peter T., Golub, Leon, Jacyna, Matthew, Johnson, David "DJ", Judge, Philip G., Klemm, Cary "Diddle", Laurent, Glenn T., Lewis, Johanna, Mallini, Charles J., Parent, Thomas "Duster", Propp, Timothy, Steffl, Andrew J., Warner, Jeff, West, Matthew J., Wiseman, John, Yates, Mallory, Zhukov, Andrei N., Team, the NASA WB-57 2017 Eclipse Observing

Publikováno v: The Astrophysical Journal, Vol. 895, Issue 2, 131 (14pp); 2020 June 1

NASA's WB-57 High Altitude Research Program provides a deployable, mobile, stratospheric platform for scientific research. Airborne platforms are of particular value for making coronal observations during total solar eclipses because of their ability

Externí odkaz: http://arxiv.org/abs/2004.09658

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions.

Autor: Loan Nguyen TM; Université Paris-Saclay, Faculté de Pharmacie, Inserm UMR 1018, CESP, MOODS Team, 91400 Orsay, France., Guilloux JP; Université Paris-Saclay, Faculté de Pharmacie, Inserm UMR 1018, CESP, MOODS Team, 91400 Orsay, France., Defaix C; Université Paris-Saclay, Faculté de Pharmacie, Inserm UMR 1018, CESP, MOODS Team, 91400 Orsay, France., Mendez-David I; Université Paris-Saclay, Faculté de Pharmacie, Inserm UMR 1018, CESP, MOODS Team, 91400 Orsay, France., Etting I; Service de Pharmacologie-Toxicologie, Hôpital Raymond Poincaré, Groupe Hospitalier Universitaires AP-HP, Université Paris-Saclay, Inserm U-1018, CESP, MOODS Team, 92380 Garches, France., Alvarez JC; Service de Pharmacologie-Toxicologie, Hôpital Raymond Poincaré, Groupe Hospitalier Universitaires AP-HP, Université Paris-Saclay, Inserm U-1018, CESP, MOODS Team, 92380 Garches, France., McGowan JC; Department of Psychiatry, Columbia University, New York, NY, 10032, USA; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc. (RFMH) /New York State Psychiatric Institute (NYSPI), New York, NY, 10032, USA; Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, MA, 02478, USA., Highland JN; Departments of Psychiatry, Baltimore, MD, USA; Departments of Program in Toxicology, University of Maryland School of Medicine, Baltimore, MD, USA; Veterans Affairs Maryland Health Care System, Baltimore, MD, 21201, USA., Zanos P; Departments of Psychiatry, Baltimore, MD, USA; Departments of Pharmacology, Baltimore, MD, USA; Departments of Physiology, Baltimore, MD, USA; Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA; Department of Psychology, University of Cyprus, Nicosia, 2109, Cyprus., Lovett J; Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA., Moaddel R; Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA., Corruble E; Université Paris-Saclay, Faculté de Médecine, Inserm UMR 1018, CESP, MOODS Team, 94270 Bicêtre Hospital, 94270 Le Kremin-Bicêtre, France; Service Hospitalo-Universitaire de Psychiatrie de Bicêtre, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre, 94270 Le Kremlin Bicêtre, France., David DJ; Université Paris-Saclay, Faculté de Pharmacie, Inserm UMR 1018, CESP, MOODS Team, 91400 Orsay, France., Gould TD; Departments of Psychiatry, Baltimore, MD, USA; Departments of Pharmacology, Baltimore, MD, USA; Departments of Physiology, Baltimore, MD, USA; Departments of Neurobiology, Baltimore, MD, USA; Departments of Program in Toxicology, University of Maryland School of Medicine, Baltimore, MD, USA; Veterans Affairs Maryland Health Care System, Baltimore, MD, 21201, USA; Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA., Denny CA; Department of Psychiatry, Columbia University, New York, NY, 10032, USA; Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc. (RFMH) /New York State Psychiatric Institute (NYSPI), New York, NY, 10032, USA., Gardier AM; Université Paris-Saclay, Faculté de Pharmacie, Inserm UMR 1018, CESP, MOODS Team, 91400 Orsay, France. Electronic address: alain.gardier@universite-paris-saclay.fr.

Publikováno v: Neuropharmacology [Neuropharmacology] 2024 Nov 01; Vol. 258, pp. 110065. Date of Electronic Publication: 2024 Jul 14.

When antidepressants meet the gut microbiota: implications and challenges.

Autor: Cussotto S; Université Paris-Saclay, UVSQ, Centre de recherche en Epidémiologie et Santé des Populations (CESP), UMR 1018, CESP-Inserm, Team Moods, Faculté de Pharmacie, Bâtiment Henri Moissan, Orsay., Colle R; Université Paris-Saclay, Centre de recherche en Epidémiologie et Santé des Populations (CESP), MOODS UMR1018, CESP-Inserm, Team Moods, Faculté de Médecine, Le Kremin-Bicêtre.; Service Hospitalo-Universitaire de Psychiatrie, Hôpital de Bicêtre, Hôpitaux Universitaires Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France., David DJ; Université Paris-Saclay, UVSQ, Centre de recherche en Epidémiologie et Santé des Populations (CESP), UMR 1018, CESP-Inserm, Team Moods, Faculté de Pharmacie, Bâtiment Henri Moissan, Orsay., Corruble E; Université Paris-Saclay, Centre de recherche en Epidémiologie et Santé des Populations (CESP), MOODS UMR1018, CESP-Inserm, Team Moods, Faculté de Médecine, Le Kremin-Bicêtre.; Service Hospitalo-Universitaire de Psychiatrie, Hôpital de Bicêtre, Hôpitaux Universitaires Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.

Publikováno v: International clinical psychopharmacology [Int Clin Psychopharmacol] 2025 Jan 01; Vol. 40 (1), pp. 46-48. Date of Electronic Publication: 2024 Nov 27.